GGrantIndex
Sort

11,323 grants matching glioblastoma

Development of a Novel Class of Highly Specific and Effective Oncolytic HSV Vect

$365,804
Joseph C. Glorioso · Ohio State University · P01 · FY2015 · CA

Evaluation of Novel Dually Targeted Kinase Inhibitors for Therapy of Adult and Pediatric High-Grade Glioma

$365,801
Joya Chandra · University Of Tx Md Anderson Can Ctr · R33 · FY2021 · NS

Glioblastoma Phenotype Modulation Through miRNA Control of Wnt Signaling

$365,774
Shi-Yuan Cheng · Northwestern University At Chicago · R01 · FY2015 · NS

Glioma Therapy Using Targeted Oncolytic HSV Vectors

$365,663
Joseph C. Glorioso · University Of Pittsburgh At Pittsburgh · R01 · FY2010 · CA

Identification and targeting of mechanisms specific to glioma stem cells in glioblastoma

$365,646
Daniel J Brat · Northwestern University At Chicago · R01 · FY2020 · CA

Project 4: Activity of CAR T cell Therapy for Patients with Metastatic TNBC

$365,428
Gianpietro Dotti · Univ Of North Carolina Chapel Hill · P50 · FY2025 · CA

Understanding Mechanisms of Resistance to Anti-angiogenic Treatments

$365,426
Ali Syed Arbab · Augusta University · R01 · FY2015 · CA

The Heterogeneity of Glioblastoma Multiforme and its Applications towards the Dev

$365,361
Paul S Mischel · California Institute Of Technology · U54 · FY2012 · CA

The epigenetic mechanisms of high-grade pediatric glioblastoma

$365,351
Zhiguo Zhang · Columbia University Health Sciences · R01 · FY2021 · CA

The epigenetic mechanisms of high-grade pediatric glioblastoma

$365,349
Zhiguo Zhang · Columbia University Health Sciences · R01 · FY2020 · CA

The epigenetic mechanisms of high-grade pediatric glioblastoma

$365,348
Zhiguo Zhang · Columbia University Health Sciences · R01 · FY2018 · CA

Bone marrow derived neural stem cell therapy for glioma

$365,313
John S Yu · Cedars-Sinai Medical Center · R01 · FY2012 · NS

Bone marrow derived neural stem cell therapy for glioma

$365,313
John S Yu · Cedars-Sinai Medical Center · R01 · FY2011 · NS

Genetic Mouse Models of Glioma

$365,222
Luis F Parada · Ut Southwestern Medical Center · R01 · FY2013 · CA

Project 2: Analyses of the human GBM microenvironment form clinical trial specimens treated with the oncolytic HSV, rQNestin34v.2

$365,084
E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2025 · CA

Genetic Modulation of Cognitive Function and outcomes in Glioblastoma Patients

$365,069
Melissa L Bondy · University Of Tx Md Anderson Can Ctr · P50 · FY2011 · CA

Renal Function In Transgenic Mice

$365,007
Jurgen B. Schnermann · Diabetes, Digestive, Kidney Diseases · Z01 · FY2007 · DK

Renal and extrarenal effects of adenosine 1 receptors

$365,007
Jurgen Schnermann · Diabetes, Digestive, Kidney Diseases · Z01 · FY2007 · DK

Cancer stem cells and human liver cancer

$364,963
Snorri Thorgeirsson · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA

CORE--ANIMAL MODELS

$364,928
Terry A Van Dyke · Univ Of North Carolina Chapel Hill · P30 · FY2007 · CA

Gene Delivery Nanoparticles to Treat Glioblastoma

$364,921
Jordan Green · Johns Hopkins University · R01 · FY2021 · CA

Gene Delivery Nanoparticles to Treat Glioblastoma

$364,921
Jordan Green · Johns Hopkins University · R01 · FY2020 · CA

GENETICALLY ENGINEERED VIRUSES FOR BRAIN TUMOR THERAPY

$364,893
Massachusetts General Hospital · R01 · FY2002 · NS

The Heterogeneity of Glioblastoma Multiforme and its Applications towards the Dev

$364,827
Paul S Mischel · California Institute Of Technology · U54 · FY2011 · CA

Physiologically Based Pharmacokinetic Modeling of Drug Penetration into the Human Brain and Brain Tumors

$364,825
Jing Li · Wayne State University · R01 · FY2025 · CA